Skip to main content
Log in

Antineoplastics/pegfilgrastim

Treatment refractoriness, off-label use and leucopenia in the form of neutropenia: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Harrer DC, et al. Gemcitabine Maintenance Therapy in Patients With Metastasized Soft Tissue Sarcomas. Frontiers in Oncology 11: 1-7, Dec 2021. Available from: URL: http://doi.org/10.3389/fonc.2021.755439

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics/pegfilgrastim. Reactions Weekly 1891, 45 (2022). https://doi.org/10.1007/s40278-022-09297-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09297-3

Navigation